A new drug that could help reduce damage to the body after a heart attack, stroke or major surgery has been developed by UK scientists.
Tests in mice suggest the compound protects the heart when blood flow is restored suddenly after a period when tissue has been starved of oxygen. MitoSNO has yet to be tested on humans, but could lead to a whole new class of medicines.
The research is published in the journal Nature Medicine.
One of the problems after a heart attack is the damage caused to heart tissue when blood flow is restored suddenly after a prolonged period without oxygen. Blood flowing back into the tissues triggers production of harmful molecules, called free radicals, which are generated inside mitochondria - the powerhouses of the cell.
Donald Trump a letter on Monday asking him to withdraw his nomination for a top drug...
Health care consumers will suffer from President Trump's decision to cut off ObamaCare's cost-sharing reduction (CSR) subsidies,...
